Kerry Reinertsen

Senior Vice President, Strategic Alliances · Regeneron Pharmaceuticals

Biopharmaceuticals

Kerry Reinertsen is senior vice president of strategic alliances at Regeneron Pharmaceuticals. She joined in 2011 after business development and corporate development leadership at Millennium, Vertex and Constellation Pharmaceuticals.

Last reviewed: Oct 21, 2026

Kerry Reinertsen

Senior Vice President, Strategic Alliances Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Kerry Reinertsen is senior vice president of strategic alliances at Regeneron Pharmaceuticals. She joined in 2011 after business development and corporate development leadership at Millennium, Vertex and Constellation Pharmaceuticals.

Career Highlights

  • Joined Regeneron in 2011.
  • Previously served as chief business officer at Constellation Pharmaceuticals.
  • Earlier served as vice president of corporate development at Vertex Pharmaceuticals.

Professional Journey

Reinertsen began her biotechnology career at Millennium Pharmaceuticals, now Takeda Oncology. She held increasingly responsible business development positions there before serving as vice president of Corporate Development at Vertex Pharmaceuticals.

She subsequently became chief business officer of Constellation Pharmaceuticals. These roles combined business development and corporate leadership within biotechnology companies before her move to Regeneron in 2011.

She now serves as senior vice president of Strategic Alliances. Her career brings doctoral training in biological chemistry and molecular pharmacology together with experience in the business relationships supporting pharmaceutical research. Her undergraduate studies in molecular biology and economics also reflect the scientific and commercial sides of that background.

Education

Reinertsen earned a PhD in biological chemistry and molecular pharmacology from Harvard University. She holds an ScB in molecular biology and an AB in economics from Brown University.